401 results on '"Schaiquevich, Paula"'
Search Results
2. SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas
3. Full Validation and Application to Clinical Research of a High-Performance Liquid Chromatography Method for the Assessment of Urinary 3-Indoxyl Sulfate in Pediatric Patients with Hematopoietic Stem Cell Transplant.
4. Time Estimation of Topotecan Penetration in Retinoblastoma Cells Through Image Sequence Analysis
5. A decision process for drug discovery in retinoblastoma
6. 213.5: The Potential Role of HLA Molecular Mismatch in Biopsy-proven Rejection in Pediatric Liver Transplantation
7. Treatment of graft versus host disease with photopheresis interferes in voriconazole therapeutic drug monitoring: A case study
8. Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases
9. Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma
10. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression
11. Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”
12. Feasibility of steroid-free tacrolimus-basiliximab immunosuppression in pediatric liver transplantation and predictors for steroid requirement.
13. Pharmacokinetics of Orbital Topotecan After Ophthalmic Artery Chemosurgery and Intravenous Infusion in the Swine Model
14. Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies
15. Immunohistochemical expression of TFF1 is a new prognostic marker in retinoblastoma
16. An Ultra-fast UHPLC-MS/MS Method for Cannabidiol Monitoring in Pediatric Refractory Epilepsy
17. Time Estimation of Topotecan Penetration in Retinoblastoma Cells Through Image Sequence Analysis
18. Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier
19. FEASIBILITY OF STEROID-FREE TACROLIMUS-BASILIXIMAB IMMUNOSUPPRESSION IN PEDIATRIC LIVER TRANSPLANTATION
20. Sustained-release hydrogels of topotecan for retinoblastoma
21. Pharmacokinetics of Chemotherapy Delivered by Ophthalmic Artery Chemosurgery
22. Supplementary Tables S1-S2 from Population Pharmacokinetic Analysis of Topotecan in Pediatric Cancer Patients
23. Reply
24. A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma
25. Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination
26. SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery
27. evaluación de desempeño del servicio de dosificación de precisión para vancomicina en un hospital pediátrico de nivel terciario
28. Population pharmacokinetics of sublingually administered tacrolimus in infants and young children with liver transplantation
29. A pharmacometrics model to define docetaxel target in early breast cancer
30. Follow‐up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients
31. Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing
32. Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma
33. High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma
34. Survival Time to Biopsy-Proven Acute Rejection and Tacrolimus Adverse Drug Reactions in Pediatric Liver Transplantation
35. Abstract 2500: Metastatic retinoblastoma exhibit MYCN alterations, recurrent CNAs and hypomethylation as molecular characteristics of aggressive disease
36. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina
37. Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients
38. Treatment of Retinoblastoma: What Is the Latest and What Is the Future
39. OCULAR PHARMACOLOGY OF CHEMOTHERAPY FOR RETINOBLASTOMA
40. Population pharmacokinetics of sublingually administered tacrolimus in infants and young children with liver transplantation.
41. A pharmacometrics model to define docetaxel target in early breast cancer.
42. Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing.
43. Follow‐up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients.
44. Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts
45. Management of Retinoblastoma in Children: Current Status
46. Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases
47. Clinical pharmacology of cannabidiol in refractory epilepsy
48. Therapeutic monitoring of pediatric renal transplant patients with conversion to generic cyclosporin
49. Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma
50. Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.